title: Endocrinopathies in women during opioid therapy cause loss of androgens, fatigue, listlessness, loss of libido and quality of life: stop prescribing opioids or follow the 2016 Centers for Disease Control and Prevention guidelines?
authors: Department of Pain Management and Research, Oslo University Hospital, Norway.|Department of Anesthesiology, Oslo University Hospital, Norway.|Faculty of Medicine, University of Oslo, Institute of Clinical Medicine, Oslo, Norway.
authors: Harald
authors: H
authors: Breivik
authors: Department of Pain Management and Research, Oslo University Hospital, Norway.|Faculty of Medicine, University of Oslo, Institute of Clinical Medicine, Oslo, Norway.
authors: Audun
authors: A
authors: Stubhaug
mesh_terms: D000701:Analgesics, Opioid / Q000627:therapeutic use*; D000728:Androgens; D002487:Centers for Disease Control and Prevention, U.S.; D005260:Female; D006801:Humans; D007989:Libido; D011788:Quality of Life
chemical_list: D000701:Analgesics, Opioid; D000728:Androgens